Our analysis identified six key immune regulatory genes (TLR2, TLR4, CCR7, IL18, TIRAP and FOXP3) that show differential expression between lung cancer and normal tissues and demonstrate potential prognostic value. This evidence concerns the gene CCR7 and lung cancer.